Investigating the Efficacy, Safety and PK of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD

NCT04621331 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor's decision

Conditions

Anemia Associated With Chronic Kidney Disease

Interventions

DRUG: Roxadustat

Sponsor

Kyntra Bio

Collaborators

[object Object]